Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription

被引:1
作者
Sunthorn Muangmingsuk
Paul Ingram
Mahesh P. Gupta
Rene A. Arcilla
Madhu Gupta
机构
[1] The University of Illinois,The Heart Institute for Children, Hope Children's Hospital
[2] The University of Chicago,Department of Cardiac Surgery
来源
Molecular and Cellular Biochemistry | 2000年 / 209卷
关键词
myosin heavy chain; gene expression; hypertrophy; dexamethasone; promoter function;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac hypertrophy has been observed in newborn infants treated with dexamethasone (DEX). This study was undertaken to examine whether DEX-induced hypertrophy in newborn rats is associated with redistribution of cardiac myosin heavy chain (MHC) isoforms and if so, the effects involve transcriptional regulation. Newborn rats were injected with either DEX (1 mg/kg/day; s.c.) or equivalent volume normal saline for 1, 3, 5, 7 or 9 days. Hypertrophy was quantified by heart dry/wet wt ratios, heart/body wt ratios, and total protein content of the myocardium. Changes in the expression of cardiac MHC mRNA were characterized by northern blot and slot blot analyses, using isoform specific probes for a- and β-MHC genes. DEX effect on α-MHC gene transcription was analyzed by transiently transfecting various α-MHC promoter/CAT reporter constructs into primary cultures of cardiac myocytes derived from one day old rat pups. DEX administration into newborn rats produced significant cardiac hypertrophy ranging from 23% at day 1 to 59% at 9 days. The hypertrophy was accompanied by immediate increase (83%) in steady state level of the α-MHC mRNA within one day and a maximum increase (148%) at 7 days of treatment. The steady state level of β-MHC mRNA declined by 25% at day 1 and a maximum decrease of 54% at day 7 of DEX treatment. The changes in MHC mRNA were also reflected in their protein levels as determined by V1 and V3 isozyme analysis. DEX treatment of primary cultures of cardiomyocytes following transfection with a-MHC promoter/CAT reporter constructs resulted in increased CAT expression in a dose dependent manner. The minimum α-MHC gene sequences responding to DEX treatment were located between the -200 to -74-bp region of the gene, resulting in 2-fold and 6-fold activation of CAT reporter after 0.05 and 0.1 mM doses of DEX, respectively. Our data indicate that DEX induced cardiac hypertrophy in newborn rats is accompanied by increased expression of α-MHC and decreased expression of β-MHC. The α-MHC effects are mediated in part through transcriptional mechanisms.
引用
收藏
页码:165 / 174
页数:9
相关论文
共 168 条
[1]  
Cummings JJ(1989)A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia New Engl J Med 320 1504-1510
[2]  
D'Eugenio DB(1992)Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia J Pediatr 120 286-291
[3]  
Gross SJ(1996)Cardiac effect of dexamethasone in very low birth weight infants Pediatrics 97 818-821
[4]  
Werner JC(1993)Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia Am Heart J 125 253-258
[5]  
Sicard RE(1995)Reversible steroidinduced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns Am J Perinatology 12 271-274
[6]  
Hansen WR(1997)Indicators of delayed maturation of rat heart treated prenatally with dexamethasone Ped Res 42 139-144
[7]  
Solomon E(1992)Glucocorticoids accelerated the ontogenetic transition of cardiac ventricular myosin heavy-chain isoform expression in the rat: Promotion by prenatal exposure to a low dose of dexamethasone J Dev Phys 18 35-42
[8]  
Cowett RM(1992)Dexamethasone induces a transient relative cardiomegaly in neonatal rats Ped Res 31 359-363
[9]  
Oh W(1990)Glucocorticoid modulation of cardiac mass and protein Med Sci Sports Exer 22 312-315
[10]  
Bensky AS(1995)Biochemical correlates of dexamethasoneinduced relative cardiomegaly in neonatal rats In vivo 9 75-80